Armata Pharmaceuticals, Inc.
ARMP
$2.68
$0.2510.29%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -149.50% | -351.19% | 147.44% | -160.99% | 135.91% |
| Total Depreciation and Amortization | -2.92% | -0.79% | 21.41% | -0.63% | -0.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4,778.60% | 98.11% | -338.26% | 85.33% | -219.00% |
| Change in Net Operating Assets | -66.75% | -200.67% | 227.17% | -41.45% | 60.93% |
| Cash from Operations | 4.87% | 4.38% | 10.56% | 12.91% | 3.85% |
| Capital Expenditure | -50.51% | -228.57% | 122.65% | 75.11% | -446.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -50.51% | -228.57% | 122.65% | 75.11% | -446.40% |
| Total Debt Issued | -100.00% | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | 109.52% |
| Repurchase of Common Stock | 100.00% | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | 100.00% | -169.32% | -99.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -419.03% | 129.39% | 15.26% | 19.13% | -147.54% |